SBFM

Sunshine Biopharma
SBFM

Overview Fund Activity

12 hedge funds and large institutions have $187K invested in Sunshine Biopharma in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
+1
Holders Change %
+9.09%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Citadel Advisors
Citadel Advisors
Florida
+$91.3K
2
Renaissance Technologies
Renaissance Technologies
New York
+$77.9K
3
SM
Sabby Management
Florida
+$2.24K
4
SS
SBI Securities
Japan
+$2.12K

Top Sellers

1
UBS Group
UBS Group
Switzerland
-$28.4K
2
RA
Rise Advisors
New York
-$2
Name Holding Trade Value Shares
Change 		Shares
Change %
Citadel Advisors
1
Citadel Advisors
Florida
$91.3K +$91.3K +63,431 New
Renaissance Technologies
2
Renaissance Technologies
New York
$77.9K +$77.9K +54,093 New
SS
3
SBI Securities
Japan
$9.64K +$2.12K +1,471 +28%
Morgan Stanley
4
Morgan Stanley
New York
$5.52K – – –
SM
5
Sabby Management
Florida
$2.24K +$2.24K +1,558 New
UBS Group
6
UBS Group
Switzerland
$297 -$28.4K -19,679 -99%
National Bank of Canada
7
National Bank of Canada
Quebec, Canada
$14 – – –
Bank of America
8
Bank of America
North Carolina
$7 – – –
Osaic Holdings
9
Osaic Holdings
Arizona
$6 – – –
FFA
10
Farther Finance Advisors
California
$1 – – –
TWC
11
TD Waterhouse Canada
Ontario, Canada
$1 – – –
FDCDDQ
12
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1 – – –
ACM
13
Altium Capital Management
New York
– -$96.4K -50,466 Closed
RA
14
Rise Advisors
New York
– -$2 -1 Closed